症状性腹主动脉瘤修复术后的远期结局
单中心研究纳入1995至2015年修复的症状性腹主动脉瘤139例与无症状选择性腹主动脉瘤1054例,症状性组远期生存较低,动脉瘤相关再干预率相似,女性在症状性腹主动脉瘤中修复时主动脉直径显著小于男性。
要点
- 症状性腹主动脉瘤修复后5年及10年生存率低于无症状选择性腹主动脉瘤。
- 症状性腹主动脉瘤的动脉瘤相关再干预率与无症状选择性腹主动脉瘤相似。
- 女性因症状性腹主动脉瘤接受修复时的主动脉直径显著小于男性。
核心结论
- 症状性腹主动脉瘤患者修复后远期生存低于无症状选择性腹主动脉瘤患者,动脉瘤相关再干预率相似。
- 女性因症状性腹主动脉瘤接受修复时的主动脉直径显著小于男性,强调性别在腹主动脉瘤症状学中的作用。
- 远期生存差异可能仅部分由已测量的患者、动脉瘤和手术因素解释,可能反映未测量的社会因素或提示症状性腹主动脉瘤病理生理的内在差异。
研究设计与样本
- 单中心学术机构研究,纳入1995年至2015年因症状性腹主动脉瘤和无症状选择性腹主动脉瘤接受修复的患者。
- 排除破裂性腹主动脉瘤及肾上或胸腹主动脉瘤。
- 收集人口学、合并症和手术方式,主要结局为远期死亡率,通过病历回顾或链接社会保障死亡索引确定。
- 采用最近邻倾向性匹配减少偏倚后比较远期死亡率和再干预。
主要发现
- 症状性腹主动脉瘤139例(开放修复60例[43%],腔内修复79例[57%]),无症状选择性腹主动脉瘤1054例(开放修复383例[36%],腔内修复671例[64%])。
- 症状性组与无症状选择性组年龄(73岁 vs 74岁;P = .13)和动脉瘤直径(6.0 cm vs 5.8 cm;P = .5)相似。
- 症状性组女性比例更高(26% vs 16%;P = .003),非白种人比例更高(40% vs 29%;P = .009)。
- 围手术期死亡率症状性组为5.0%,无症状选择性组为2.3%(P = .055)。
- 全队列寿命表分析显示症状性组5年生存率(62% vs 71%)和10年生存率(39% vs 51%)低于无症状选择性组(P = .01)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Previous studies have reported increased perioperative mortality of nonruptured symptomatic abdominal aortic aneurysms (Sx-AAA) compared with asymptomatic elective AAA (E-AAA) repairs, but no long-term-outcomes have been reported. We sought to compare long-term outcomes of Sx-AAA and E-AAA after repair at a single academic institution. METHODS: Patients receiving AAA repair for Sx-AAA and E-AAA from 1995 through 2015 were included. Ruptured AAA and suprarenal or thoracoabdominal AAA were excluded. Demographics, comorbidities, and operative approach were collected. Long-term mortality was the primary outcome, determined by chart review or link to Social Security Death Index. Additionally, long-term mortality and reinterventions were compared after groups were matched with nearest neighbor propensity to reduce bias. RESULTS: AAA repair was performed for 1054 E-AAA (383 open repair [36%], 671 endovascular aneurysm repair [EVAR] [64%]), and 139 symptomatic aneurysms (60 open repair [43%], 79 EVAR [57%]). Age (73 years vs 74 years; P = .13) and aneurysm diameter were similar between Sx-AAA and E-AAA (6.0 cm vs 5.8 cm; P = .5). The proportion of women was higher for Sx-AAA (26% vs 16%; P = .003), as was the proportion of non-Caucasians (40% vs 29%; P = .009). After propensity matching, there were no differences between groups for patient characteristics, AAA diameter, treatment modality, or comorbidities, including hypertension, coronary artery disease, congestive heart failure, diabetes, hyperlipidemia, lung disease, diabetes, renal disease, and smoking history. Women were treated for Sx-AAA at significantly smaller aortic diameters; however, compared with men (5.1 cm vs 6.3 cm; P < .001). Perioperative mortality was 5.0% for Sx-AAA and 2.3% for E-AAA (P = .055). By life-table analysis, Sx-AAA had lower 5-year (62% vs 71%) and 10-year (39% vs 51%) survivals (P = .01) compared with E-AAA for the entire cohort. Similar trends were observed for 5-year and 10-year mortality after propensity matching (63% and 40% vs 71% and 52%; P = .05). When stratified by repair type 5-year and 10-year survivals trended lower after open surgery (68% and 42% Sx-AAA vs 84% and 59% E-AAA; P = .08) but not EVAR (59% and 40% Sx-AAA vs 61% and 49% E-AAA; P = .4). Aneurysm-related reinterventions were similar for Sx-AAA and E-AAA (15% vs 14%; P = .8). Reinterventions were more common after EVAR compared with open repair (22% vs 7%, Sx-AAA P = .015; 20% vs 4% E-AAA; P = .007). CONCLUSIONS: Patients with Sx-AAA had lower long-term survival and similar aneurysm-related reinterventions compared with patients with E-AAA undergoing repair. Women also underwent repair for Sx-AAA at a significantly smaller size when compared with men, which emphasizes the role of gender in AAA symptomatology. Differences in long-term survival may be only partially explained by measured patient, aneurysm, and operative factors, and may reflect unmeasured social factors or suggest inherent differences in pathophysiology of Sx-AAAs.
引用
- Chandra V, Trang K, Virgin-Downey W, et al. Long-term outcomes after repair of symptomatic abdominal aortic aneurysms. J Vasc Surg. 2018. PMID: 29705087. doi:10.1016/j.jvs.2018.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。